PV Bulletin
PvBulletin

Tag archive

Aggregate Reporting

Country GuidesMhraUnited Kingdom

MHRA clarifies PSUR submission routes for Category 1 vs Category 2

Relevant for
Local Safety OfficerSignal Management LeadRegulatory Intelligence LeadPV Operations Lead+3 more
Action needed

1) Map portfolio to MHRA’s Category 1 vs Category 2/NI MA status referenced in the Windsor Framework PV guidance; 2) Update PSUR submission SOPs/work-instructions and submission trackers to ensure Category 1 PSURs route via the MHRA PSUR portal and Category 2/NI MA PSURs route via the EU PSUR Repository (and confirm when no separate MHRA submission is needed); 3) Re-check related MHRA PV procedure guidance for any additional submission/documentation expectations impacting signals, RMPs and PASS.

Process impact
Signal ValidationLocal Affiliate ComplianceInspection Readiness
SOP impact

8 SOPs may need review

Urgency: HighConfidence: high
Read impact brief
Country GuidesHealth Canada

Health Canada Q&A accepts PSUR or PBRER for C.01.018 reports

Relevant for
Local Safety OfficerSignal Management LeadPV Quality LeadPV Technology / CSV Lead+2 more
Action needed

Health Canada update requires triage for Local Affiliate Compliance, Inspection Readiness, Risk Management; confirm local obligations and document follow-up actions.

Process impact
Local Affiliate ComplianceInspection ReadinessRisk Management
SOP impact

5 SOPs may need review

Urgency: HighConfidence: medium
Read impact brief
Country GuidesMhra

UK MHRA refreshes PV procedures and adds decentralised manufacture UK GVP

Relevant for
Local Safety OfficerSignal Management LeadRegulatory Intelligence LeadPV Operations Lead+4 more
Action needed

Mhra update requires triage for Signal Validation, Risk Management, Local Affiliate Compliance; confirm local obligations and document follow-up actions.

Process impact
Signal ValidationRisk ManagementLocal Affiliate Compliance
SOP impact

9 SOPs may need review

Urgency: HighConfidence: medium
Read impact brief
LatestEma

MaaT Pharma flags CHMP “negative trend” ahead of June vote

Relevant for
Signal Management LeadLabeling LeadRegulatory Intelligence LeadPV Technology / CSV Lead+2 more
Action needed

Ema update requires triage for Label Governance, Risk Management, AI / GxP Governance; confirm local obligations and document follow-up actions.

Process impact
Label GovernanceRisk ManagementAI / GxP Governance
SOP impact

5 SOPs may need review

Urgency: MediumConfidence: medium
Read impact brief

Get updates for your PV role

Subscribe to receive impact-first pharmacovigilance updates tailored by role and workflow.

Current context: role All, workflow Risk Management.